In pain R&D, Vertex withstood tough times to bring non-opioid suzetrigine to cusp of FDA approval

Two decades ago, when two genetic mutations were discovered in Asia that gave scientists a better idea of how pain sensations traveled through the body and identified which part of the nervous system to target, the race was on in biopharma to develop a non-opioid pain relief medicine.